Overview

Impact of Cilostazol Versus Cilostazol and Selenium Combination on the Healing of Diabetic Foot Ulcer Patients

Status:
Recruiting
Trial end date:
2025-12-03
Target enrollment:
Participant gender:
Summary
The growing incidence of DM can lead to the increased prevalence of diabetic foot complications, which have become a serious medical, social, and economic concern of global importance. this study aims to find a novel intervention that improve wound healing in diabetic foot ulcer to improve patients' quality of life, reduce amputation rate, and reduce the mortality rate among diabetic foot ulcer patients
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Ain Shams University
Treatments:
Cilostazol
Selenium